📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

GA2LEN ANACARE consensus statement: Potential of omalizumab in food allergy management. (2024)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/clt2.70002

PubMed Identifier: 39506193

Publication URI: http://europepmc.org/abstract/MED/39506193

Type: Journal Article/Review

Volume: 14

Parent Publication: Clinical and translational allergy

Issue: 11

ISSN: 2045-7022